Rodyti straipsnį

Ortopedinė chirurgija

Priešoperacinis paciento įvertinimas ir transfuzijos rizikos įvertinimas

Estimating the transfusion risk following total knee arthroplasty. (atsiveria naujas langas)

Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P.

Šaltinis‎: Orthopedics 2012;35(10):e1465-71.

Kodas‎: PubMed 23027481

DOI‎: 10.3928/01477447-20120919-13

https://www.ncbi.nlm.nih.gov/pubmed/23027481 (atsiveria naujas langas)

Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. (atsiveria naujas langas)

Bebbington A, Kulkarni R, Roberts P.

Šaltinis‎: J Arthroplasty 2005;20(1):125-6.

Kodas‎: PubMed 15660071

DOI‎: 10.1016/j.arth.2004.02.031

https://www.ncbi.nlm.nih.gov/pubmed/15660071 (atsiveria naujas langas)

Factors affecting transfusion requirement after hip fracture: can we reduce the need for blood? (atsiveria naujas langas)

Desai SJ, Wood KS, Marsh J, Bryant D, Abdo H, Lawendy AR, Sanders DW.

Šaltinis‎: Can J Surg 2014;57(5):342-8.

Kodas‎: PubMed 25265109

https://www.ncbi.nlm.nih.gov/pubmed/25265109 (atsiveria naujas langas)

Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. (atsiveria naujas langas)

Walsh TS, Palmer J, Watson D, Biggin K, Seretny M, Davidson H, Harkness M, Hay A.

Šaltinis‎: Br J Anaesth 2012;108(1):63-71.

Kodas‎: PubMed 22037224

DOI‎: 10.1093/bja/aer326

https://www.ncbi.nlm.nih.gov/pubmed/22037224 (atsiveria naujas langas)